VNDA vs XPEV · rev $102.2M vs rev $895.7M
Vanda Pharmaceuticals Inc (VNDA) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
VNDA currently screens at market cap $358.4M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the VNDA and XPEV stock pages for the full models.
Not investment advice.